Innovative Value-Based Medicine: Lessons from China's Healthcare Evolution

3,525
Total downloads
15k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 08 Sep 2025

Impact of China’s National Volume-Based Procurement policy exclusively for insulin on the volume, expenditure and price: an interrupted time series analysis in Guangdong Province

Changsong Jiang
Manling Nie
Yun Lu
Ting Jiang
Dan Guo
Peng Qi
Na Li
Feng Chang

doi 10.3389/fpubh.2025.1659721

343 views

ORIGINAL RESEARCH

Published on 05 Sep 2025

Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China

Cong Wang
Xihan Lin
Jinyu Liu
Yu Zhang
Ruxu You

doi 10.3389/fpubh.2025.1596676

605 views

ORIGINAL RESEARCH

Accepted on 04 Sep 2025

Unpacking the Cost Implications of Diagnosis-Related Groups Reform for Lumbar Disc Herniation Patients in Chinese Medicine: A Closer Look at Evidence from China

Mengen Chen
Yu-Han Wang
Jing Yu
Shi-Ji Xia
Xiao-Xi Zhang
Yan Wang
You-Shu Yuan
Xuan Jia
He-Nong Sun
6 more
Zhi-Wei Wang

doi 10.3389/fpubh.2025.1631872

105 views

ORIGINAL RESEARCH

Published on 29 Aug 2025

A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in China

Yizhou Xu
Junjie Wan
Bin Wan
Haixia Ding

doi 10.3389/frhs.2025.1650709

515 views

ORIGINAL RESEARCH

Accepted on 25 Aug 2025

A Queuing Game Theory Approach to Strategies for Supplementing Medical Alliances with Internet Hospitals

Xin Zhang
Yue Meng
JiaChun Li

doi 10.3389/fpubh.2025.1610722

401 views

ORIGINAL RESEARCH

Published on 12 Jun 2025

Evaluating and enhancing the service capacity of secondary public hospitals in urban China: a multi-method empirical analysis based on Guangzhou (2019–2023)

Baoling Wu
Wenbo Wu
Xi Wang
Weizhang Huang
Zhenni Luo
Jifeng Li

doi 10.3389/frhs.2025.1621018

914 views

ORIGINAL RESEARCH

Published on 11 Jun 2025

Can the Marketing Authorisation Holder system improve the ESG performance of pharmaceutical manufacturers?

Jiajing Li

doi 10.3389/fpubh.2025.1587028

850 views

ORIGINAL RESEARCH

Published on 09 Jun 2025

A study of the impact of DIP payment reform on coronary heart disease hospitalization costs and equity

Yingying Tao
Keyi Shen
Yating Chen
Chengcheng Li
Dan Wu
Xuehui Meng

doi 10.3389/fpubh.2025.1567838

1,094 views

ORIGINAL RESEARCH

Published on 30 May 2025

Facilitators and barriers to the implementation of DIP payment methodology reform in a public hospital in Guangzhou: a qualitative study based on the implementation of the meta-framework for research (CFIR) framework

Jinghui Chang
Siyi Chen
Anqi Li
Xixi Yang
Hualian Luo
Maidina Yilamu
Bingqian Fu
Nuoyan Xu
Jing Liu
Huishu Tian

doi 10.3389/fpubh.2025.1569855

1,080 views

ORIGINAL RESEARCH

Published on 27 May 2025

Cost-effectiveness analysis of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer: a Markov’s model-based evaluation

Juan Hong
Xiaohui Zeng
Wenjun Chen
Ziyuan Zhou
Yuming He
Jun Meng
Lihui Ouyang

doi 10.3389/fpubh.2025.1574780

989 views

ORIGINAL RESEARCH

Published on 23 May 2025

The impact of digital economy on the supply chain resilience of cross-border healthcare e-commerce

Jianyu Liu
Siyi Mao
Lin Lu
Yuan Jing
Xiangjun Yang
Hejiang Xu
Yuelin Ren

doi 10.3389/fpubh.2025.1570338

1,565 views
1 citation

ORIGINAL RESEARCH

Published on 16 May 2025

Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America

Jing Yang
Fang Chen
Junlin Li
Yujie Zhou
Hao Wang
Yunchun Long

doi 10.3389/fimmu.2025.1556100

1,575 views
1 citation

Share on

Frontiers in Public Health

Health Economics

Participating Journals

Frontiers in Health Services
- Cost and Resource Allocation
- 2.7 impact factor
- 2.5 citescore

Impact

15kTopic views
10kArticle views
3,525Article downloads

View impact

Articles

Impact of China’s National Volume-Based Procurement policy exclusively for insulin on the volume, expenditure and price: an interrupted time series analysis in Guangdong Province

Cost-effectiveness analysis of Chinese patent medicines for the treatment of postmenopausal osteoporosis in China

Unpacking the Cost Implications of Diagnosis-Related Groups Reform for Lumbar Disc Herniation Patients in Chinese Medicine: A Closer Look at Evidence from China

A multi-stakeholder multicriteria decision analysis for implantable medical devices assessment in China

A Queuing Game Theory Approach to Strategies for Supplementing Medical Alliances with Internet Hospitals

Evaluating and enhancing the service capacity of secondary public hospitals in urban China: a multi-method empirical analysis based on Guangzhou (2019–2023)

Can the Marketing Authorisation Holder system improve the ESG performance of pharmaceutical manufacturers?

A study of the impact of DIP payment reform on coronary heart disease hospitalization costs and equity

Facilitators and barriers to the implementation of DIP payment methodology reform in a public hospital in Guangzhou: a qualitative study based on the implementation of the meta-framework for research (CFIR) framework

Cost-effectiveness analysis of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer: a Markov’s model-based evaluation

The impact of digital economy on the supply chain resilience of cross-border healthcare e-commerce

Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America

Frontiers in Public Health

Health Economics

Participating Journals

Frontiers in Health Services

Cost and Resource Allocation